Erik Feldmann currently serves as the Technical Director at Cambrex, where he plays a pivotal role in advancing the development of innovative pharmaceutical solutions. With a robust background in pharmaceuticals and biotechnology, Erik specializes in drug discovery and development, focusing on both small and large...
Erik Feldmann currently serves as the Technical Director at Cambrex, where he plays a pivotal role in advancing the development of innovative pharmaceutical solutions. With a robust background in pharmaceuticals and biotechnology, Erik specializes in drug discovery and development, focusing on both small and large molecule drug products. His expertise extends to regulatory testing and the manufacturing of biologics, making him a key asset in supporting early clinical stage development.
At Cambrex, Erik is actively involved in several high-impact projects that aim to streamline the transition from laboratory research to clinical application. His work encompasses the design and optimization of biophysical and biochemical assays, ensuring that drug candidates are rigorously evaluated for efficacy and safety. Erik’s proficiency in molecular biology and protein chemistry enables him to lead initiatives in protein engineering, where he applies advanced techniques such as X-ray crystallography and NMR spectroscopy to elucidate protein structures and functions.
In addition to his technical skills, Erik is adept at grant writing and technical presentations, skills that are essential for securing funding and communicating complex scientific concepts to diverse audiences. His experience with chromatography and characterization techniques further enhances his ability to deliver high-quality biopharmaceutical products. As a thought leader in the field, Erik continues to drive innovation at Cambrex, contributing to the development of next-generation therapies that address unmet medical needs.
